| Name | dronedarone |
|---|---|
| Synonyms |
UNII-JQZ1L091Y2
N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide Multaq N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-1-benzofuran-5-yl)methanesulfonamide Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]- Dronedarone N-(2-Butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide |
| Description | Dronedarone(Multaq) is a newer therapeutic agent with a structural resemblance to amiodarone and a better side effect profile; it is a multichannel blocker with antiadrenergic properties and has been evaluated in both rate and rhythm control strategies in the management of AF.IC50 value:Target: multichannel blocker |
|---|---|
| Related Catalog | |
| References |
[3]. Rosman J, et al. Possible Proarrhythmia with Dronedarone.J Cardiovasc Electrophysiol. 2012 Jul 19. |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 683.9±65.0 °C at 760 mmHg |
| Molecular Formula | C31H44N2O5S |
| Molecular Weight | 556.756 |
| Flash Point | 367.4±34.3 °C |
| Exact Mass | 556.297119 |
| PSA | 97.23000 |
| LogP | 7.58 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.564 |
| Storage condition | -20°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 3004909090 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 3004909090 |
|---|